 |
|
|
| |
Real World Effectiveness of Ledipasvir/Sofosbuvir in Treatment-Experienced Cirrhotic Genotype 1 Patients with Chronic HCV: A Comparative Analysis of Gilead Sponsored Trials with 4 Real-World Cohorts
|
| |
| |
Reported by Jules Levin
DDW My 22-24 San Diego, CA
Steven Flamm1, Apurva A. Modi2, Surakit Pungpapong3, Michael D. Leise4, Bashar Aqel5, Joseph Llewellyn6, Jian Zhang6, Laurie Williams6, Macky Natha6, Bruce Kreter6, John McNally6, Diana Brainard6, Anita Kohli7, David L. Wyles8, Yoori Lee9, K Rajender Reddy10, Michael Curry11 1Northwestern University Feinberg School of Medicine, Chicago, IL; 2Baylor Scott and White, Fort Worth, TX; 3Mayo Clinic, FL; 4Mayo Clinic, MN 5Mayo Clinic, AZ; 6Gilead Sciences Foster City, CA; 7Creighton University, SJHMC, Phoenix, AZ; 8University of California, San Diego, CA; 9TRIO Health Analytics; 10University of Pennsylvania, PA; 11Beth Israel Deaconess, Boston, MA
|
| |
|
|
|
|
|
